EI
INFI

EAM Investors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

EAM Investors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-840,556
Closed -$1M – 367
2022
Q3 		$1M Buy
+840,556
New +$907K 0.22% 215
2021
Q1 		– Sell
-421,103
Closed -$893K – 471
2020
Q4 		$893K Buy
+421,103
New +$694K 0.15% 275
2015
Q1 		– Sell
-80,859
Closed -$1.37M – 407
2014
Q4 		$1.37M Sell
80,859
-11
-0% -$160 0.19% 236
2014
Q3 		$1.08M Buy
+80,870
New +$963K 0.22% 242

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

EAM Investors's INFI Position: Q4 2022 in Review

EAM Investors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 840,556 shares — an estimated $1M sold.

EAM Investors first reported a position in INFI in Q3 2014 and held it in 4 quarters. The position peaked at $1.37M in Q4 2014. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • EAM Investors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • EAM Investors sold 840,556 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1M.
  • EAM Investors first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
  • EAM Investors's Infinity Pharmaceuticals, Inc. position peaked at $1.37M in Q4 2014.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.